Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 07, 2024

BUY
$191.17 - $325.63 $14.8 Million - $25.2 Million
77,368 Added 41.75%
262,675 $85.5 Million
Q1 2024

May 09, 2024

BUY
$191.17 - $325.63 $50.2 Million - $85.5 Million
262,675 New
262,675 $85.5 Million
Q3 2023

Oct 07, 2024

SELL
$194.33 - $283.97 $41.6 Million - $60.7 Million
-213,865 Reduced 53.58%
185,307 $36.9 Million
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $41.6 Million - $60.7 Million
-213,865 Reduced 53.58%
185,307 $36.9 Million
Q2 2023

Oct 07, 2024

BUY
$223.05 - $302.68 $83.1 Million - $113 Million
372,413 Added 1391.73%
399,172 $114 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $83.1 Million - $113 Million
372,413 Added 1391.73%
399,172 $114 Million
Q1 2023

Oct 07, 2024

SELL
$175.41 - $217.92 $36 Million - $44.7 Million
-205,170 Reduced 88.46%
26,759 $5.8 Million
Q1 2023

May 12, 2023

SELL
$175.41 - $217.92 $36 Million - $44.7 Million
-205,170 Reduced 88.46%
26,759 $5.8 Million
Q4 2022

Oct 07, 2024

BUY
$204.38 - $296.82 $47.4 Million - $68.8 Million
231,929 New
231,929 $47.7 Million
Q4 2022

Feb 10, 2023

SELL
$204.38 - $296.82 $70.3 Million - $102 Million
-343,866 Reduced 59.72%
231,929 $47.7 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $38 Million - $60.4 Million
194,429 Added 50.98%
575,795 $160 Million
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $26.5 Million - $49.1 Million
-228,871 Reduced 37.51%
381,366 $72.9 Million
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $5.39 Million - $8.73 Million
42,115 Added 7.41%
610,237 $127 Million
Q4 2021

Feb 11, 2022

SELL
$165.13 - $241.83 $4.3 Million - $6.3 Million
-26,059 Reduced 4.39%
568,122 $101 Million
Q3 2021

Nov 09, 2021

SELL
$163.99 - $235.57 $52 Million - $74.7 Million
-317,294 Reduced 34.81%
594,181 $122 Million
Q2 2021

Aug 11, 2021

BUY
$131.45 - $201.49 $13 Million - $20 Million
99,246 Added 12.22%
911,475 $173 Million
Q1 2021

May 11, 2021

BUY
$92.73 - $142.05 $22.7 Million - $34.7 Million
244,624 Added 43.1%
812,229 $106 Million
Q4 2020

Feb 09, 2021

BUY
$67.44 - $103.72 $17.2 Million - $26.5 Million
255,470 Added 81.85%
567,605 $58.9 Million
Q3 2020

Nov 12, 2020

BUY
$42.79 - $75.8 $6.84 Million - $12.1 Million
159,955 Added 105.11%
312,135 $23.7 Million
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $2.02 Million - $3.53 Million
-74,216 Reduced 32.78%
152,180 $7.21 Million
Q1 2020

May 14, 2020

SELL
$23.16 - $47.74 $4.04 Million - $8.32 Million
-174,254 Reduced 43.49%
226,396 $7.51 Million
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $5.84 Million - $8.94 Million
198,666 Added 98.36%
400,650 $17.6 Million
Q3 2019

Nov 14, 2019

SELL
$29.71 - $55.23 $2.55 Million - $4.73 Million
-85,670 Reduced 29.78%
201,984 $6.05 Million
Q2 2019

Aug 14, 2019

BUY
$29.73 - $66.02 $1.49 Million - $3.31 Million
50,083 Added 21.08%
287,654 $16.4 Million
Q1 2019

May 15, 2019

BUY
$29.41 - $38.1 $6.99 Million - $9.05 Million
237,571 New
237,571 $7.95 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.